Table 1.
Basic patient demographics,
| UC | CD | Non-IBD | |
|---|---|---|---|
| n = 20 | n = 7 | n = 8 | |
| Age [years] | |||
| Mean [SD] | 35.77 [13.57] | 49.28 [20.8] | 30.17 [15.33] |
| Range | 24–77 | 26–74 | 21–65 |
| Gender [% male] | 60 | 42 | 25 |
| Duration of UC/CD [years] | |||
| Mean [SD] | 10.56 [8.78] | 11.14 [7.05] | |
| Range | 1–23 | 0–20 | |
| SCCAI31/CDAI44 | |||
| Mean [SD] | 5.89 [3.26] | 144 [152.9] | |
| Range | 0–12 | 0–349 | |
| Treatment [current] | |||
| TNFα-blocker | 4 | 1 | |
| Vedolizumab | 8 | 3 | |
| Mesalazine | 6 | ||
| Glucocorticoids | 2 | 1 | |
| JAK Inhibitor | 2 | 1 |
IBD, inflammatory bowel disease; UC,ulcerative colitis; CD, Crohn’s disease; SD, standard deviation; SCCAI, Simple Clinical Colitis Activity Index; CDAI, Crohn’s Disease Activity Index.